Monte Rosa Therapeutics Company Contacts

Monte Rosa Therapeutics

http://www.monterosatx.com
Monte Rosa Therapeutics is a clinical-stage biotechnology company developing highly selective molecular glue degrader (MGD) medicines for patients living with serious diseases in the areas of oncology, autoimmune and inflammatory diseases, and more. Monta Rosa’s QuEEN™ (Quantitative and Engineered Elimination... Read More
Contacts

Country

United States

City

Boston

Headquarters

Boston, Massachusetts

Profile

Industry

Biotechnology Research

Size

51 - 200

Funding

Total Rounds

5

Last Round

Wed May 15 2024

Last Round Series

Post IPO equity

Last Round Raised

$ 100,000,000